Overview
News
Technologies
Salaries
Products
People
Growth
Financials

Overview

BlueDot is a Toronto company founded in 2013 that tracks infectious disease risk using machine learning over news reports, official bulletins, flight itineraries and climate data. It became widely known for flagging the outbreak that became COVID-19 in the final days of 2019, ahead of public health announcements. Governments, hospitals and businesses use its surveillance and forecasting products to prepare for emerging threats.

News

News infectioncontroltoday 5 days ago
Strategies on Emerging Pathogens for Infection Preventions Infection Control Today
A presentation at APIC 2024 will feature strategies for combating emerging pathogens, emphasizing preparedness for infection preventionists amid rising global health threats, including dengue, measles, and new unknown pathogens.
Read more
Report
Blog 3 months ago
Estimating true size of the Ebola Bundibugyo virus disease outbreak in the Democratic Republic of Congo as of June 9, 2026
Updated from the May 22, 2026 report.This free report examines the likely true size of the current Ebola Bundibugyo virus disease outbreak in the Democratic Republic of the Congo (DRC).Official figures likely underestimate the scale of the outbreak, which
Read more
Report
Blog 4 months ago
Your Risk Map Is Outdated: What the 2026 World Cup Reveals About the New Travel Health Landscape
The World Cup is a massive event that will expose how profoundly the infectious disease landscape has changed in recent years. Organizations dealing with static assumptions about disease threats may be caught by surprise. On June 11, the 2026 World Cup ki
Read more
Report
Blog 5 months ago
What can we learn from Measles in the US?
The largest US measles outbreak in over 25 years is unfolding, exposing a complex dynamic between risk, hesitancy and vaccination. Organizations everywhere can learn much from it. Nestled between the bigger cities of Charlotte and Greenville, Spartanburg
Read more
Report
Pro access
Upgrade to see all 30 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.